Associated Papers
The silent players: Atypical BCR‑ABL isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review).
Zhou X et al.
Oncology Reports, 2025
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Sanchez R et al.
Annals of Hematology, 2017
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Khorashad JS et al.
Blood, 2013
Associations between imatinib resistance conferring mutations and Philadelphia positive clonal cytogenetic evolution in CML.
Schnittger S et al.
Genes, Chromosomes & Cancer, 2010
Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X et al.
Journal of the National Cancer Institute, 2007
Select a paper to view details